ORCID
ORCID (Open Researcher and Contributor ID):
ORCID of corresponding author(s) should be described.
https://orcid.org/
All Issue
Vol.26 No.3
September 30, 2021 eISSN 2288-3657
pISSN 2288-3649
September 30, 2021 eISSN 2288-3657
pISSN 2288-3649
Most KeyWord
Most Read
-
Recent Advances in the Development of TGF-β Signaling Inhibitors for Anticancer Therapy
Ho-Jae Lee
J Cancer Prev 2020;25: 213-222 https://doi.org/10.15430/JCP.2020.25.4.213 -
Targeting Epigenetic ‘Readers’ with Natural Compounds for Cancer Interception
Elisabetta Damiani,*, Munevver N. Duran, Nivedhitha Mohan, Praveen Rajendran,*, Roderick H. Dashwood,*
J Cancer Prev 2020;25: 189-203 https://doi.org/10.15430/JCP.2020.25.4.189
Most Downloaded
-
Recent Advances in the Development of TGF-β Signaling Inhibitors for Anticancer Therapy
Ho-Jae Lee
J Cancer Prev 2020;25: 213-222 https://doi.org/10.15430/JCP.2020.25.4.213 -
Targeting Epigenetic ‘Readers’ with Natural Compounds for Cancer Interception
Elisabetta Damiani,*, Munevver N. Duran, Nivedhitha Mohan, Praveen Rajendran,*, Roderick H. Dashwood,*
J Cancer Prev 2020;25: 189-203 https://doi.org/10.15430/JCP.2020.25.4.189